LysoPC a C20:4
|
Basic information |
| Metabolite name | LysoPC a C20:4 |
 | N/A |
 |
C04230 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | LysoPC a C20:4 |
| N/A |
|
C04230 |
|
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between LysoPC a C20:4 and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M741 | Type2 | MDD group, post vs. before SSRI treatment | Plasma | Human | Down |
| Study M741 | Type4 | remitter group vs. non-remitter group, posttreatment | Plasma | Human | Up |
| Study M962 | Type2 | 24h-post ketamine infusion vs. baseline | Plasma | Human | Up |